A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD	Cognition Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyskinesias, Huntington disease, Machado-Joseph disease, Neurologic Manifestations, Spinocerebellar Ataxias, Spinocerebellar Degenerations, atactic disorder, non-human animal, basal ganglia disorder, brain disorder, central nervous system disorder, cerebellar ataxia, cerebellar disorder, choreatic disease, cognitive disorder, dementia, hereditary disease, inherited neurodegenerative disorder, movement disorder, nervous system disorder, neurodegenerative disease, psychiatric disorder, spinal cord disorder, spinocerebellar ataxia type 1	Recruiting	Phase 1 / Phase 2	2026-08-19		NCT05822908

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Vico Therapeutics B. V.	1

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Centre Hospitalier Universitaire dÁngers	Angers	France	1
CHU Gui de Chauliac Montpellier- Expert Center of Neurogenetic diseases, Department of Neurology	Montpellier	France	1
Deutsches Zentrum fur Neurodegenerative Erkrankungen (DZNE)	Bonn	Germany	1
John Radcliffe Hospital	Oxford	United Kingdom	15
Katholisches Klinikum Bochum	Bochum	Germany	3
Leiden University Medical Center LUMC	Leiden	Netherlands	1
Meir Medical Center	Kfar Saba	Israel	29
Radbout University Medical Centre	Nijmegen	Netherlands	1
Rigshospitalet	Copenhagen	Denmark	84
Sourmansky Medical Center	Tel Aviv	Israel	1
Universitatsklinikum Essen - Neurologie	Essen	Germany	1
Universitatsklinikum Tübingen	Tübingen	Germany	1
University College London Hospitals NHS Foundation	London	United Kingdom	1
Universtiry Hospitals Pitie Salpetriere - Charles foix - Paris	Paris	France	1